首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Effect of cardiac surgery on maternal and perinatal outcome in rheumatic heart disease with pregnancy: a comparative study
【24h】

Effect of cardiac surgery on maternal and perinatal outcome in rheumatic heart disease with pregnancy: a comparative study

机译:心脏手术对风湿性心脏病妊娠合并孕妇和围产儿结局的影响:一项比较研究

获取原文
       

摘要

Background: Rheumatic heart disease remains the commonest heart disease in India with mitral stenosis being the most common lesion and is associated with significant maternal and perinatal mortality and morbidity. The objective of this study was to compare maternal and perinatal outcome in women with rheumatic heart valvular disease who had no surgery or had percutaneous balloon mitral valvuloplasty (PBMV) or had valvular replacement surgery. Methods: It was a retrospective study in 113 women with rheumatic heart disease with various valvular lesion admitted in the hospital in previous 10 years. There were 58 (51.35%) patients without cardiac surgery (Group 1), 24 (21.23%) with PTMC (Group 2) and 31 (27.43%) with valve replacement surgery (Group 3). Maternal and perinatal outcome were compared in three groups. Results: The baseline characteristics were similar in the three group. In cardiac complications New York Heart Association (NYHA) deterioration was significantly higher (24.1%) in non-operated group (Group 1) as compared to Group 2 (12.3%) and Group 3 (16.1%). There was no difference in Group 2 and Group 3. Need of cardiac medication (digoxin) was also highest (67.2%) in Group 1 as compared to Group 2 (24.6%) (p = 0.002) and Group 3 (38.7%) (p = 0.001) but no difference in Group 2 and Group 3. Anticoagulant were given to significantly higher number (54.8% of cases in Group 3 (valve replacement) as compared to Group 1 (3.4%) and Group 2 (12.5%). There was no significant difference in obstetric events and mode of delivery in the three groups. Similarly, there was no difference in fetal outcome in the three groups as regard to mean birth weight, APGAR score, fetal growth restriction, fetal or neonatal death or congenital anomalies in the three groups. Conclusions: Cardiac surgery before or during pregnancy did not significantly improve maternal or perinatal outcome. Only cardiac events and need of medication was reduced with surgery. Hence surgery should be performed judiciously in selected cases.
机译:背景:风湿性心脏病仍然是印度最常见的心脏病,二尖瓣狭窄是最常见的病变,并与孕妇和围产期的死亡率和发病率显着相关。这项研究的目的是比较风湿性心脏瓣膜疾病的妇女的母亲和围产期结局,这些妇女没有进行手术或经皮球囊二尖瓣成形术(PBMV)或进行了瓣膜置换手术。方法:这是一项回顾性研究,研究对象是过去10年中住院的113例风湿性心脏病患者,患有各种瓣膜病变。有58例(51.35%)患者未进行心脏手术(第1组),24例(21.23%)接受PTMC(第2组)和31例(27.43%)接受了瓣膜置换手术(第3组)。将三组孕妇和围产期结局进行了比较。结果:三组的基线特征相似。在心脏并发症中,与第二组(12.3%)和第三组(16.1%)相比,非手术组(第一组)的纽约心脏协会(NYHA)恶化显着更高(24.1%)。第2组和第3组没有差异。与第2组(24.6%)(p = 0.002)和第3组(38.7%)相比,第1组对心脏药物(地高辛)的需求也最高(67.2%)( p = 0.001),但在第2组和第3组中没有差异。与第1组(3.4%)和第2组(12.5%)相比,给予抗凝剂的人数(第3组(瓣膜置换)占病例的54.8%)明显更高。三组的产科事件和分娩方式无显着差异,三组的平均平均体重,APGAR评分,胎儿生长受限,胎儿或新生儿死亡或先天性胎儿结局也无差异结论:三组异常:结论:妊娠前或妊娠期间的心脏手术并不能显着改善孕产妇或围产期的结局,只有心脏事件和药物需要减少,因此在某些情况下应明智地进行手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号